Further Information
MECOM, MDS1 and EVI1 complex locus, AML1-EVI-1, EVI1, MDS1, MDS1-EVI1, MGC163392, MGC97004, PRDM3, AML1-EVI-1 fusion protein, ecotropic viral integration site 1, myelodysplasia syndrome 1, myelodysplasia syndrome-associated protein 1, oncogene EVI1, zinc finger protein Evi1
Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx 170kDa band observed in lysates of cell lines A549 and HepG2 (calculated MW of 126kDa according to NP_001098547.3). The observed molecular weight corresponds to earlier findings with different antibodies from other commercial sources. Recommended concentration: 1-3ug/ml.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-DKESLHSTSH
2122
MDS1 and EVI1 complex locus
MECOM
Homo sapiens
Liquid
NP_001098547.3, NP_005232.2, NP_004982.2, NP_001157471.1, NP_001157472.1
255683379
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognize all reported isoforms (NP_001098547.3; NP_005232.2; NP_004982.2; NP_001157471.1; NP_001157472.1). Reported variants represent identical protein: NP_001098548.2, NP_005232.2
Q03112